Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.
2.

Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial Substudy.

Beale AL, Nanayakkara S, Kaye DM.

J Am Heart Assoc. 2019 Jul 2;8(13):e012190. doi: 10.1161/JAHA.119.012190. Epub 2019 Jun 22.

3.

Venoarterial extracorporeal membrane oxygenation: A systematic review of selection criteria, outcome measures and definitions of complications.

Burrell AJC, Bennett V, Serra AL, Pellegrino VA, Romero L, Fan E, Brodie D, Cooper DJ, Kaye DM, Fraser JF, Hodgson CL; International ECMO Network (ECMONet).

J Crit Care. 2019 May 24;53:32-37. doi: 10.1016/j.jcrc.2019.05.011. [Epub ahead of print]

PMID:
31181462
4.

Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention.

Warren J, Nanayakkara S, Andrianopoulos N, Brennan A, Dinh D, Yudi M, Clark D, Ajani AE, Reid CM, Selkrig L, Shaw J, Hiew C, Freeman M, Kaye D, Kingwell BA, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators.

J Am Coll Cardiol. 2019 Jun 11;73(22):2846-2855. doi: 10.1016/j.jacc.2019.03.493.

PMID:
31171090
5.

Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D.

Open Heart. 2019 Apr 3;6(1):e001012. doi: 10.1136/openhrt-2019-001012. eCollection 2019.

6.

Reply: The Importance of Baseline Physical Activity Level in Heart Failure With Preserved Ejection Fraction.

Beale AL, Nanayakkara S, Kaye DM.

JACC Heart Fail. 2019 Jun;7(6):535-536. doi: 10.1016/j.jchf.2019.03.013. No abstract available.

PMID:
31146881
7.
8.

The role of the gut microbiome in sex differences in arterial pressure.

Beale AL, Kaye DM, Marques FZ.

Biol Sex Differ. 2019 Apr 25;10(1):22. doi: 10.1186/s13293-019-0236-8. Review.

9.

Electrical Phenotype in Heart Failure With Preserved Ejection Fraction: Disease Severity Marker or Therapeutic Target?

Kaye DM, Patel HC.

JACC Heart Fail. 2019 May;7(5):428-430. doi: 10.1016/j.jchf.2019.02.005. Epub 2019 Apr 10. No abstract available.

PMID:
30981743
10.

Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.

Sugumar H, Nanayakkara S, Prabhu S, Voskoboinik A, Kaye DM, Ling LH, Kistler PM.

Cardiol Clin. 2019 May;37(2):131-138. doi: 10.1016/j.ccl.2019.01.002. Epub 2019 Feb 20. Review.

PMID:
30926014
11.

Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy.

Savira F, Magaye R, Hua Y, Liew D, Kaye D, Marwick T, Wang BH.

Toxicol Lett. 2019 Jun 15;308:34-49. doi: 10.1016/j.toxlet.2019.03.002. Epub 2019 Mar 11. Review.

PMID:
30872129
12.

Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology.

Normand C, Kaye DM, Povsic TJ, Dickstein K.

Lancet. 2019 Mar 9;393(10175):1045-1055. doi: 10.1016/S0140-6736(18)32216-5. Review.

PMID:
30860030
13.

Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.

Wolsk E, Kaye D, Komtebedde J, Shah SJ, Borlaug BA, Burkhoff D, Kitzman DW, Lam CSP, van Veldhuisen DJ, Ponikowski P, Petrie MC, Hassager C, Møller JE, Gustafsson F.

JACC Heart Fail. 2019 Apr;7(4):321-332. doi: 10.1016/j.jchf.2019.01.006. Epub 2019 Mar 6.

PMID:
30852235
14.

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy.

Chu PY, Joshi MS, Horlock D, Kiriazis H, Kaye DM.

Front Pharmacol. 2019 Feb 19;10:117. doi: 10.3389/fphar.2019.00117. eCollection 2019.

15.

Make a Joyful Noise: Integrating Music into Child Psychiatry Evaluation and Treatment.

Bostic JQ, Thomas CR, Beresin EV, Rostain AL, Kaye DL.

Child Adolesc Psychiatr Clin N Am. 2019 Apr;28(2):195-207. doi: 10.1016/j.chc.2018.11.003. Epub 2019 Feb 6. Review.

PMID:
30832952
16.

Resting and Exercise Doppler Hemodynamics: How and Why?

Nanayakkara S, Kaye DM, Marwick TH.

Heart Fail Clin. 2019 Apr;15(2):229-239. doi: 10.1016/j.hfc.2018.12.003. Epub 2019 Feb 2. Review.

PMID:
30832814
17.

Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.

Beale AL, Nanayakkara S, Segan L, Mariani JA, Maeder MT, van Empel V, Vizi D, Evans S, Lam CSP, Kaye DM.

JACC Heart Fail. 2019 Mar;7(3):239-249. doi: 10.1016/j.jchf.2019.01.004.

PMID:
30819380
18.
19.

Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.

Ginsburg KB, Arcot R, Qi J, Linsell SM, Kaye DR, George AK, Cher ML; MUSIC.

J Urol. 2019 May;201(5):923-928. doi: 10.1097/JU.0000000000000059.

PMID:
30694939
20.

Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program.

Kaye DR, Dunn RL, Li J, Herrel LA, Dupree JM, Miller DC, Ellimoottil C.

J Surg Res. 2019 Apr;236:30-36. doi: 10.1016/j.jss.2018.09.073. Epub 2018 Dec 4.

PMID:
30694769
21.

Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction.

Telles F, Nanayakkara S, Evans S, Patel HC, Mariani JA, Vizi D, William J, Marwick TH, Kaye DM.

Eur J Heart Fail. 2019 Apr;21(4):495-505. doi: 10.1002/ejhf.1399. Epub 2019 Jan 16.

PMID:
30652393
22.

Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population.

Kaye DR, Luckenbaugh AN, Oerline M, Hollenbeck BK, Herrel LA, Dimick JB, Hollingsworth JM.

Ann Surg. 2018 Dec 20. doi: 10.1097/SLA.0000000000003165. [Epub ahead of print]

PMID:
30601252
23.

Population-Based Gut Microbiome Associations With Hypertension.

Jama H, Kaye DM, Marques FZ.

Circ Res. 2018 Nov 9;123(11):1185-1187. doi: 10.1161/CIRCRESAHA.118.313792. No abstract available.

PMID:
30571464
24.

The gut microbiota and blood pressure in experimental models.

Jama HA, Kaye DM, Marques FZ.

Curr Opin Nephrol Hypertens. 2019 Mar;28(2):97-104. doi: 10.1097/MNH.0000000000000476.

PMID:
30531472
25.

Comparison of Commonly Used Questionnaires to Identify Obstructive Sleep Apnea in a High-Risk Population.

Kee K, Dixon J, Shaw J, Vulikh E, Schlaich M, Kaye DM, Zimmet P, Naughton MT.

J Clin Sleep Med. 2018 Dec 15;14(12):2057-2064. doi: 10.5664/jcsm.7536.

26.

Characterising risk of in-hospital mortality following cardiac arrest using machine learning: A retrospective international registry study.

Nanayakkara S, Fogarty S, Tremeer M, Ross K, Richards B, Bergmeir C, Xu S, Stub D, Smith K, Tacey M, Liew D, Pilcher D, Kaye DM.

PLoS Med. 2018 Nov 30;15(11):e1002709. doi: 10.1371/journal.pmed.1002709. eCollection 2018 Nov.

27.

Decompression With or Without Fusion for Adjacent Segment Disease Without Instability.

Wanderman N, Geletta M, Sharma R, Sebastian A, Kaye D.

Clin Spine Surg. 2019 Jun;32(5):179-181. doi: 10.1097/BSD.0000000000000750. No abstract available.

PMID:
30475242
28.

Longer Preoperative Duration of Symptoms Negatively Affects Health-related Quality of Life After Surgery for Cervical Radiculopathy.

Tarazona D, Boody B, Hilibrand AS, Stull J, Bell K, Fang T, Goyal D, Galetta M, Kaye D, Kepler CK, Kurd MF, Woods BI, Radcliff KE, Rihn JA, Anderson DG, Vaccaro AR, Schroeder GD.

Spine (Phila Pa 1976). 2019 May 15;44(10):685-690. doi: 10.1097/BRS.0000000000002924.

PMID:
30395087
29.

Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.

Wessler J, Kaye D, Gustafsson F, Petrie MC, Hasenfuβ G, Lam CSP, Borlaug BA, Komtebedde J, Feldman T, Shah SJ, Burkhoff D; REDUCE-LAP-HF Trial Investigators and Advisors.

Circ Heart Fail. 2018 Aug;11(8):e004540. doi: 10.1161/CIRCHEARTFAILURE.117.004540.

PMID:
30354556
30.

Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.

Giam B, Chu PY, Kuruppu S, Smith AI, Horlock D, Murali A, Kiriazis H, Du XJ, Kaye DM, Rajapakse NW.

Exp Physiol. 2018 Dec;103(12):1593-1602. doi: 10.1113/EP087189. Epub 2018 Nov 5.

PMID:
30311699
31.

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators.

ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.

32.

Exercise training in heart failure: a long way to go yet.

Patel HC, Kaye DM.

Eur J Heart Fail. 2018 Dec;20(12):1744-1745. doi: 10.1002/ejhf.1332. Epub 2018 Oct 9. No abstract available.

PMID:
30298968
33.

Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.

Kaye DR, Qi J, Morgan TM, Linsell S, Ginsburg KB, Lane BR, Montie JE, Cher ML, Miller DC; Michigan Urological Surgery Improvement Collaborative.

BJU Int. 2019 May;123(5):846-853. doi: 10.1111/bju.14554. Epub 2018 Oct 15.

PMID:
30248225
34.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L.

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

PMID:
30167646
35.

Privacy and genetic genealogy data.

Greytak EM, Kaye DH, Budowle B, Moore C, Armentrout SL.

Science. 2018 Aug 31;361(6405):857. doi: 10.1126/science.aav0330. No abstract available.

PMID:
30166479
36.

Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic Fibrosis.

Pallin M, Keating D, Kaye DM, Kotsimbos T, Wilson JW.

Clin Med Insights Circ Respir Pulm Med. 2018 Aug 19;12:1179548418794154. doi: 10.1177/1179548418794154. eCollection 2018.

37.

Regression of Diffuse Ventricular Fibrosis Following Restoration of Sinus Rhythm With Catheter Ablation in Patients With Atrial Fibrillation and Systolic Dysfunction: A Substudy of the CAMERA MRI Trial.

Prabhu S, Costello BT, Taylor AJ, Gutman SJ, Voskoboinik A, McLellan AJA, Peck KY, Sugumar H, Iles L, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Lee G, Mariani J, Kaye DM, Ling LH, Kalman JM, Kistler PM.

JACC Clin Electrophysiol. 2018 Aug;4(8):999-1007. doi: 10.1016/j.jacep.2018.04.013. Epub 2018 Jun 27.

PMID:
30139501
38.

Enhancing self-care strategies in heart failure through patient-reported outcome measures.

Segan L, Nanayakkara S, Mak V, Kaye D.

Intern Med J. 2018 Aug;48(8):995-998. doi: 10.1111/imj.13977.

PMID:
30133978
39.

The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.

Kaye DR, Ye Z, Li J, Herrel LA, Dupree JM, Ellimoottil C, Miller DC.

Urology. 2019 Jan;123:114-119. doi: 10.1016/j.urology.2018.04.051. Epub 2018 Aug 17.

PMID:
30125647
40.

Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure.

Nanayakkara S, Mak V, Crannitch K, Byrne M, Kaye DM.

Am J Cardiol. 2018 Sep 15;122(6):1017-1020. doi: 10.1016/j.amjcard.2018.06.009. Epub 2018 Jun 22.

PMID:
30064857
41.

Age-Related Differential Structural and Transcriptomic Responses in the Hypertensive Heart.

Marques FZ, Chu PY, Ziemann M, Kaspi A, Kiriazis H, Du XJ, El-Osta A, Kaye DM.

Front Physiol. 2018 Jul 9;9:817. doi: 10.3389/fphys.2018.00817. eCollection 2018.

42.

Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.

Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM.

Circulation. 2018 Jul 10;138(2):198-205. doi: 10.1161/CIRCULATIONAHA.118.034271. Review.

PMID:
29986961
43.

Prevalence and predictors of unknown HIV status among women delivering in Mulago National Referral Hospital, Kampala, Uganda.

Namara-Lugolobi EC, Nakigozi G, Namukwaya Z, Kaye DK, Nakku-Joloba E.

Afr Health Sci. 2017 Dec;17(4):963-973. doi: 10.4314/ahs.v17i4.3.

44.

The prognostic significance of chronotropic incompetence in patients with severe left ventricular systolic function referred for cardiac transplant assessment.

Patel HC, Yo S, Nanayakkara S, Selkrig L, Ellis MJ, Naughton MT, Kaye DM, Mariani JA.

Eur J Prev Cardiol. 2018 Jan 1:2047487318783880. doi: 10.1177/2047487318783880. [Epub ahead of print] No abstract available.

PMID:
29916724
45.

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.

Nguyen MN, Su Y, Vizi D, Fang L, Ellims AH, Zhao WB, Kiriazis H, Gao XM, Sadoshima J, Taylor AJ, McMullen JR, Dart AM, Kaye DM, Du XJ.

Sci Rep. 2018 May 29;8(1):8213. doi: 10.1038/s41598-018-26115-y.

46.

Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer.

Kaye DR, Qi J, Morgan TM, Linsell S, Lane BR, Montie JE, Cher ML, Miller DC; Michigan Urological Surgery Improvement Collaborative.

Urology. 2018 Aug;118:127-133. doi: 10.1016/j.urology.2018.04.038. Epub 2018 May 21.

PMID:
29792972
47.

Double jeopardy: Competing arrhythmias in heterotopic heart transplants.

Paratz ED, Hare JL, Kaye DM.

J Heart Lung Transplant. 2018 Jul;37(7):936-938. doi: 10.1016/j.healun.2018.03.007. Epub 2018 Mar 19. No abstract available.

PMID:
29627142
48.

Costs of Cancer Care Across the Disease Continuum.

Kaye DR, Min HS, Herrel LA, Dupree JM, Ellimoottil C, Miller DC.

Oncologist. 2018 Jul;23(7):798-805. doi: 10.1634/theoncologist.2017-0481. Epub 2018 Mar 22.

49.

Comparison of Magnetic Resonance Analysis of Myocardial Scarring With Biomarker Release Following S-T Elevation Myocardial Infarction.

Costello BT, Stub D, Hare J, Ellims AH, Wang X, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Meredith IT, Kaye DM, Iles L, Taylor AJ; AVOID Investigators.

Heart Lung Circ. 2019 Mar;28(3):397-405. doi: 10.1016/j.hlc.2018.02.007. Epub 2018 Feb 21.

PMID:
29526416
50.

System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum.

Kaye DR, Min HS, Norton EC, Ye Z, Li J, Dupree JM, Ellimoottil C, Miller DC, Herrel LA.

J Oncol Pract. 2018 Mar;14(3):e149-e157. doi: 10.1200/JOP.2017.027730. Epub 2018 Feb 13.

Supplemental Content

Support Center